Marta Germano Prado , Patrícia Teófilo Monteagudo , Glaucia Carneiro , Maria Teresa Zanella , Bianca de Almeida-Pititto
{"title":"Early- or adult-onset obesity has a similar cardiometabolic profile and weight loss response to clinical treatment in adulthood","authors":"Marta Germano Prado , Patrícia Teófilo Monteagudo , Glaucia Carneiro , Maria Teresa Zanella , Bianca de Almeida-Pititto","doi":"10.1016/j.obmed.2022.100475","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.</p></div><div><h3>Methods</h3><p>A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.</p></div><div><h3>Results</h3><p>Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) <em>vs.</em> 47.9(10.5) years, p < 0.001] and presented a higher frequency of BMI≥40kg/m<sup>2</sup> [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.</p></div><div><h3>Conclusions</h3><p>Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847622000872","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.
Methods
A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.
Results
Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) vs. 47.9(10.5) years, p < 0.001] and presented a higher frequency of BMI≥40kg/m2 [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.
Conclusions
Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.
Obesity MedicineMedicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍:
The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.